Abdoshah, M., Hosseini, H., Fallah Mehrabadi, M., Ghalyanchi Laageroudi, A. (2021). Evaluation of the infectious dose and the rate of replication of Lasota and Cloned Lasota vaccines in Newcastle disease. , 34(4), 2-7. doi: 10.22092/vj.2020.342570.1713
M Abdoshah; H Hosseini; M. H Fallah Mehrabadi; A Ghalyanchi Laageroudi. "Evaluation of the infectious dose and the rate of replication of Lasota and Cloned Lasota vaccines in Newcastle disease". , 34, 4, 2021, 2-7. doi: 10.22092/vj.2020.342570.1713
Abdoshah, M., Hosseini, H., Fallah Mehrabadi, M., Ghalyanchi Laageroudi, A. (2021). 'Evaluation of the infectious dose and the rate of replication of Lasota and Cloned Lasota vaccines in Newcastle disease', , 34(4), pp. 2-7. doi: 10.22092/vj.2020.342570.1713
Abdoshah, M., Hosseini, H., Fallah Mehrabadi, M., Ghalyanchi Laageroudi, A. Evaluation of the infectious dose and the rate of replication of Lasota and Cloned Lasota vaccines in Newcastle disease. , 2021; 34(4): 2-7. doi: 10.22092/vj.2020.342570.1713

Evaluation of the infectious dose and the rate of replication of Lasota and Cloned Lasota vaccines in Newcastle disease

تحقیقات دامپزشکی و فرآورده‌های بیولوژیک
Article 1, Volume 34, Issue 4, January 2022, Pages 2-7    PDF (592.27 K)
Document Type: Full Research Paper
DOI: 10.22092/vj.2020.342570.1713
Authors
M Abdoshah1; H Hosseini2; M. H Fallah Mehrabadi1; A Ghalyanchi Laageroudi* 3
1Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran
2Department of Clinical Sciences, Faculty of Veterinary Medicine, Karaj Branch, Islamic Azad University, Alborz, Iran
3Department of Microbiology and Immunology, University of Tehran, Faculty of Veterinary Medicine, Tehran, Iran
Abstract
Newcastle Disease is a fatal viral disease and considered a global threat to the poultry industry all over the world. Both live and killed Lentogenic, and Mesogenic vaccines are used to control this disease. One of the common vaccines used in preventing strategy of ND is the Lasota as a pneumotropic strain, which is available in two forms of Lasota and Cloned Lasota, internally produced (Razi Institute) and imported from various companies in the country, and one of the most controversial issues was the difference between Lasota and Cloned Lasota vaccines in farm conditions. In this study, the first step in the comparison was to determine the EID50 and the rate of replication, which was performed. The results showed that the used vaccines had significant differences in the amount of infectious dose. Internally produced vaccines (Razi Vaccine and Serum Institute) had an appropriate infectious dose and reproduction rate. Regarding the difference in the rate of reproduction, the primary results revealed that there is diversity between different vaccines, and this is the first step in confirming the field feedback. Due to a large amount of variety in infectious dose, in controlling the quality of vaccines, it is suggested, in addition to observation of international standard guidelines, other indicators which are monitor to their effectiveness keep to continue seriously and pay attention to cold chain and standard transport conditions.
Keywords
Newcastle disease; LaSota; Cloned LaSota; Iran
References

1- Alexander, D. J., E. W. Aldous and C. M. Fuller. 2012. The long view: a selective review of 40 years of Newcastle disease research. Avian pathology. 41: 329-335.
2- Alemian, A., S. A. Pourbakhsh, A. Shoushtari and H. Keyvanfar. 2020. Isolation and Molecular Identification of Newcastle Disease Virus in Rural Poultry in Northern Provinces of Iran. Archives of Razi Institute.
3-  Allan, W. H., J. E. Lancaster and B. Toth. 1978. Newcastle disease vaccines: Their production and use (FAO animal production and health series). Food and Agriculture Organization of the United Nations (FAO). Rome.
4- Bhuvaneswari, S., K. Tirumurugaan, P. Venkatesan, P. M. Kumar and K. Kumanan. 2017. Evaluating the efficacy of LaSota vaccination induced protection in chickens upon challenge with a genotype IV strain of Newcastle disease virus. Virus Disease. 28: 328-336.
5- Cardenas-Garcia, S., D. G. Diel, L. Susta, E. Lucio-Decanini, Q. Yu, C. C. Brown, P. J. Miller and  C. L. Afonso. 2015. Development of an improved vaccine evaluation protocol to compare the efficacy of Newcastle disease vaccines. Biologicals. 43: 136-145.
6- Cornax, I., P. J. Miller  and C. L. Afonso. 2012. Characterization of live LaSota vaccine strain–induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype. Avian Diseases. 56: 464-470.
7- Diel, D. G., L. Susta, S. C. Garcia, M. L. Killian, C. C. Brown, P. J. Miller and C. L. Afonso. 2012. Complete genome and clinicopathological characterization of a virulent Newcastle disease virus isolate from South America. Journal of Clinical Microbiology. 50: 378-387.
8- Dimitrov, K. M.,  C. L. Afonso, Q. Yu and P. J. Miller. 2017. Newcastle disease vaccines—A solved problem or a continuous challenge? Veterinary Microbiology. 206: 126-136.
9- Kaffashi, A., M. Mahmoudzadeh and S. Ataei Kachooei. 2021. Development of TaqMan Real-Time Polymerase Chain Reaction Assay for Detection of Chicken Anemia Virus in Newcastle Disease Vaccines. Archives of Razi Institute. 76: 421-427.
10- Kalantari, A., S. Farashi Bonab, H. Keyvanfar and P. Mortazavi. 2020. Evaluation of Apoptosis Induction by Newcastle Disease Virus LaSota Strain in Human Breast Carcinoma Cells. Archives of Razi Institute. 75: 367-376.
11-  Gits, J. and N.  Zygraich.1978. Potential as an aerosol vaccine of an improved Newcastle disease vaccine derived from the LaSota strain—I. In vitro studies. Comparative Immunology, Microbiology and Infectious Diseases. 1: 49-58.
12- Goldhaft, T. M. 1980. Guest editorial: Historical note on the origin of the LaSota strain of Newcastle disease virus. Avian Diseases. 24: 297-301.
13- Jeon, W. J., E.K. Lee, J.H. Kwon and K.S. Choi. 2008. Full-length genome sequence of avian paramyxovirus type 4 isolated from a mallard duck. Virus Genes. 37: 342-350.
14-  Liu, X., H. Wan, X. Ni, Y. Wu and W.  Liu. 2003. Pathotypical and genotypical characterization of strains of Newcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of China during 1985–2001. Archives of virology. 148: 1387-1403.
15- Omony, J. B., A. Wanyana, H. Kirunda, K. K. Mugimba, J. L. Nakavuma, M. Otim-Onapa  and D. K. Byarugaba. 2017. Immunogenicity and protection efficacy evaluation of avian paramyxovirus serotype-1 (APMV-1) isolates in experimentally infected chickens. Avian Pathology. 46: 386-395.
16-  Samuel, A., B. Nayak, A. Paldurai, S. Xiao, G. L. Aplogan, K. A. Awoume, R. J. Webby, M. F. Ducatez, P. L. Collins and S. K. Samal. 2013. Phylogenetic and pathotypic characterization of Newcastle disease viruses circulating in West Africa and efficacy of a current vaccine. Journal of Clinical Microbiology. 51: 771-781.

Statistics
Article View: 1,317
PDF Download: 830


counter
Journal management system. designed by sinaweb